Original Research
Published on 04 Sep 2019
An Engineered Fusion Protein Anti-CD19(Fab)-LDM Effectively Inhibits ADR-Resistant B Cell Lymphoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.00861
- 3,371 views
- 4 citations
